tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RemeGen Co., Ltd. Completes Successful Placement of H Shares
Company AnnouncementsRemeGen Co., Ltd. Completes Successful Placement of H Shares
1h ago
9995
RemeGen’s Telitacicept Gains Approval for Myasthenia Gravis Treatment in China
PremiumCompany Announcements
RemeGen’s Telitacicept Gains Approval for Myasthenia Gravis Treatment in China
2d ago
9995
RemeGen Co., Ltd. Announces 2024 AGM with Key Resolutions
PremiumCompany Announcements
RemeGen Co., Ltd. Announces 2024 AGM with Key Resolutions
3d ago
9995
RemeGen Co., Ltd. Announces Strategic Governance Changes at 2025 Shareholder Meeting
PremiumCompany Announcements
RemeGen Co., Ltd. Announces Strategic Governance Changes at 2025 Shareholder Meeting
3d ago
9995
RemeGen Co., Ltd. Enhances Governance with New Remuneration Committee
PremiumCompany Announcements
RemeGen Co., Ltd. Enhances Governance with New Remuneration Committee
3d ago
9995
RemeGen Co., Ltd. Proposes Amendments to Enhance Corporate Governance
PremiumCompany AnnouncementsRemeGen Co., Ltd. Proposes Amendments to Enhance Corporate Governance
3d ago
9995
RemeGen Co., Ltd. Updates Nomination Committee to Enhance Governance
Premium
Company Announcements
RemeGen Co., Ltd. Updates Nomination Committee to Enhance Governance
3d ago
9995
RemeGen Co., Ltd. Announces Board Composition and Roles
Premium
Company Announcements
RemeGen Co., Ltd. Announces Board Composition and Roles
3d ago
9995
RemeGen Co., Ltd. Strengthens Governance with New Audit Committee
PremiumCompany Announcements
RemeGen Co., Ltd. Strengthens Governance with New Audit Committee
3d ago
9995
RemeGen Co., Ltd. Enhances Corporate Governance with New Nomination Committee
PremiumCompany Announcements
RemeGen Co., Ltd. Enhances Corporate Governance with New Nomination Committee
3d ago
9995
RemeGen Co., Ltd. Announces New H Shares Placement to Raise HK$806 Million
PremiumCompany Announcements
RemeGen Co., Ltd. Announces New H Shares Placement to Raise HK$806 Million
7d ago
9995
RemeGen’s Disitamab Vedotin Approved for Advanced Breast Cancer Treatment in China
PremiumCompany Announcements
RemeGen’s Disitamab Vedotin Approved for Advanced Breast Cancer Treatment in China
20d ago
9995
RemeGen Co., Ltd. Releases 2025 Q1 Financial Report
PremiumCompany AnnouncementsRemeGen Co., Ltd. Releases 2025 Q1 Financial Report
1M ago
9995
RemeGen Co., Ltd. Schedules Board Meeting to Review Q1 2025 Results
Premium
Company Announcements
RemeGen Co., Ltd. Schedules Board Meeting to Review Q1 2025 Results
2M ago
9995
RemeGen Co., Ltd. Announces New Executive Director Appointment
Premium
Company Announcements
RemeGen Co., Ltd. Announces New Executive Director Appointment
2M ago
9995
RemeGen Co., Ltd. Announces Board Composition and Leadership Roles
PremiumCompany Announcements
RemeGen Co., Ltd. Announces Board Composition and Leadership Roles
2M ago
9995
RemeGen Co., Ltd. Reports Strong 2024 Revenue Growth and Pipeline Advancements
PremiumCompany Announcements
RemeGen Co., Ltd. Reports Strong 2024 Revenue Growth and Pipeline Advancements
2M ago
9995
RemeGen’s Telitacicept Study Gains Spotlight at 2025 AAN Meeting
PremiumCompany Announcements
RemeGen’s Telitacicept Study Gains Spotlight at 2025 AAN Meeting
2M ago
9995
RemeGen Co., Ltd. Schedules Board Meeting to Review Annual Results and Dividend Consideration
PremiumCompany Announcements
RemeGen Co., Ltd. Schedules Board Meeting to Review Annual Results and Dividend Consideration
2M ago
9995
RemeGen Co., Ltd. Announces 2025 EGM to Appoint New Executive Director
PremiumCompany AnnouncementsRemeGen Co., Ltd. Announces 2025 EGM to Appoint New Executive Director
3M ago
9995
RemeGen Co., Ltd. Nominates Mr. Wen Qingkai for Executive Director Role
Premium
Company Announcements
RemeGen Co., Ltd. Nominates Mr. Wen Qingkai for Executive Director Role
3M ago
9995
RemeGen Co., Ltd. Reports 2024 Financial Results with Increased Revenue but Continued Losses
Premium
Company Announcements
RemeGen Co., Ltd. Reports 2024 Financial Results with Increased Revenue but Continued Losses
3M ago
9995

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >